Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 71,506 $ 18,919
Accounts receivable, net 1,435 2,177
Other receivables 2,477 2,208
Inventory, net 16 3
Prepaid expenses and other current assets 1,408 2,660
Restricted cash, current portion 164 38
Total current assets 77,006 26,005
Property and equipment, net 1,410 1,607
Other long-term asset 2,000 0
Intangible assets, net 304 1,585
Goodwill 14,409 14,409
Restricted cash, net of current portion 227 149
Total assets 95,356 43,755
Current liabilities:    
Accounts payable 3,568 2,574
Accrued expenses and other current liabilities 15,460 11,310
Current liabilities of discontinued operations 10 1,341
Total current liabilities 19,038 15,225
Notes payable 32,483 0
Royalty obligation 2,000 2,000
Deferred tax liability, net 130 90
Other long-term liabilities 1,396 1,878
Total liabilities 55,047 19,193
Stockholders’ equity:    
Common stock—$0.001 par value; 200,000,000 shares authorized at September 30, 2021 and December 31, 2020; 112,317,829 and 75,004,127 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively 112 75
Preferred stock—$0.001 par value; 5,000,000 shares authorized at September 30, 2021 and December 31, 2020; 0 and 1,257,143 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively 0 1
Additional paid-in capital 283,167 202,276
Accumulated deficit (242,970) (177,790)
Total stockholders’ equity 40,309 24,562
Total liabilities and stockholders’ equity $ 95,356 $ 43,755